Renal Sympathetic Denervation in Patients With Drug-resistant Hypertension and Symptomatic Atrial Fibrillation

Unknown 200 enrolled The First Affiliated Hospital with Nanjing Medical University

RandomizedParallel-groupSingle-blindTreatment

Summary

To study whether renal sympathetic denervation(RSD) is safe and effective in patients with drug-resistant hypertension and symptomatic atrial fibrillation.

Timeline

Start: 2012-07
Primary completion: 2014-10
Completion: 2015-07

Publications

Qiu M, Yin Y, Shan Q. Renal sympathetic denervation versus antiarrhythmic drugs for drug-resistant hypertension and symptomatic atrial fibrillation (RSDforAF) trial: study protocol for a randomized controlled trial. Trials. 2013 Jun 11;14:168. doi: 10.1186/1745-6215-14-168.

Drugs

Evaluation	Drug	Modality	Dose	Route
Background	Amiodarone	Small molecule	—	—
Background	propafenone	Unknown	—	—

Renal Sympathetic Denervation in Patients With Drug-resistant Hypertension and Symptomatic Atrial Fibrillation

Summary

Timeline

Publications

Drugs

Indications